Table 3.
E1594: Median Overall Survival According to Histology and Chemotherapy Regimens
| Regimens | Histology | |||
|---|---|---|---|---|
| Squamous Cell Carcinoma n = 224 |
Adenocarcinoma n = 647 |
Large Cell Carcinoma n = 74 |
Others/Not Otherwise Specified n = 194 |
|
| Cisplatin-Paclitaxel - mo (95% CI) | 6.9 (5.3-9.4) | 9.1 (7.9-10.9) | 6.1 (2.9-∞) | 6.0 (3.9-9.1) |
| Cisplatin-Gemcitabine - mo (95% CI) | 9.4 (5.7-15.6) | 8.1 (6.8-9.8) | 9.7 (4.5-17.1) | 7.9 (6.3-11.3) |
| Cisplatin-Docetaxel - mo (95% CI) | 8.1 (5.5-11.2) | 7.7 (6.5-9.4) | 6.8 (5.9-11.7) | 8.2 (5.6-12.4) |
| Carboplatin-Paclitaxel - mo (95% CI) | 9.3 (7.3-12.1) | 7.6 (6.6-9.8) | 8.3 (3.6-16.7) | 6.9 (4.9-11.6) |
CI, confidence interval